European drug regulator is being investigated by fraud agencyBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7283 (Published 08 November 2011) Cite this as: BMJ 2011;343:d7283
- Zosia Kmietowicz
The agency responsible for regulating drugs across the European Union is being investigated for alleged conflicts of interest by the European Commission’s Anti-Fraud Office.
The European Medicines Agency, which is based in London, confirmed that the office has started an investigation but said that it had received no “further communication with regard to the scope and timeframe of the investigation.”
The investigation was triggered by the scandal over the French antidiabetes drug benfluorex, marketed as Mediator by the French drug company Servier. The …
Log in using your username and password
Log in through your institution
Sign up for a free trial